Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2B8Z

Crystal structure of the interleukin-4 variant R85A

Summary for 2B8Z
Entry DOI10.2210/pdb2b8z/pdb
Related2B8U 2B8X 2B8Y 2B90 2B91 2D48
DescriptorInterleukin-4, SULFATE ION (3 entities in total)
Functional Keywordsfour helix bundle, cytokine
Biological sourceHomo sapiens (human)
Cellular locationSecreted: P05112
Total number of polymer chains1
Total formula weight15287.39
Authors
Kraich, M.,Klein, M.,Patino, E.,Harrer, H.,Sebald, W.,Mueller, T.D. (deposition date: 2005-10-10, release date: 2006-05-30, Last modification date: 2024-10-09)
Primary citationKraich, M.,Klein, M.,Patino, E.,Harrer, H.,Nickel, J.,Sebald, W.,Mueller, T.D.
A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor
Bmc Biol., 4:13-13, 2006
Cited by
PubMed Abstract: Interleukin 4 (IL-4) is a key regulator of the immune system and an important factor in the development of allergic hypersensitivity. Together with interleukin 13 (IL-13), IL-4 plays an important role in exacerbating allergic and asthmatic symptoms. For signal transduction, both cytokines can utilise the same receptor, consisting of the IL-4Ralpha and the IL-13Ralpha1 chain, offering an explanation for their overlapping biological functions. Since both cytokine ligands share only moderate similarity on the amino acid sequence level, molecular recognition of the ligands by both receptor subunits is of great interest. IL-4 and IL-13 are interesting targets for allergy and asthma therapies. Knowledge of the binding mechanism will be important for the generation of either IL-4 or IL-13 specific drugs.
PubMed: 16640778
DOI: 10.1186/1741-7007-4-13
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.5 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon